The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Malyavin A.G.

Russian University of Medicine (Evdokimov Moscow State University of Medicine and Dentistry)

Tanashyan M.M.

Russian University of Medicine;
Scientific Center of Neurology»

Adasheva T.V.

Russian University of Medicine

Antonova K.V.

Scientific Center of Neurology»

Maksimova M.Y.

Research Center of Neurology

An interdisciplinary approach to assessing the risk of cerebrovascular accidents. Resolution of the Expert Council of the Russian Scientific Medical Society of Therapists

Authors:

Malyavin A.G., Tanashyan M.M., Adasheva T.V., Antonova K.V., Maksimova M.Y.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2024;124(9): 96‑99

DOI: 10.17116/jnevro202412409196

Read: 559 times

Download PDF (RU)
Contact the author
Table of contents

AN INTERDISCIPLINARY APPROACH TO ASSESSING THE RISK OF CEREBROVASCULAR ACCIDENTS. RESOLUTION OF THE EXPERT COUNCIL OF THE RUSSIAN SCIENTIFIC MEDICAL SOCIETY OF THERAPISTS
AN INTERDISCIPLINARY APPROACH TO ASSESSING THE RISK OF CEREBROVASCULAR ACCIDENTS. RESOLUTION OF THE EXPERT COUNCIL OF THE RUSSIAN SCIENTIFIC MEDICAL SOCIETY OF THERAPISTS

To cite this article:

Malyavin AG, Tanashyan MM, Adasheva TV, Antonova KV, Maksimova MY. An interdisciplinary approach to assessing the risk of cerebrovascular accidents. Resolution of the Expert Council of the Russian Scientific Medical Society of Therapists. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;124(9):96‑99. (In Russ.)
https://doi.org/10.17116/jnevro202412409196

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

An interdisciplinary approach to assessing the risk of cerebrovascular accidents. Resolution of the Expert Council of the Russian Scientific Medical Society of Therapists.

Authors:

Malyavin A.G.

Russian University of Medicine (Evdokimov Moscow State University of Medicine and Dentistry)

Tanashyan M.M.

Russian University of Medicine;
Scientific Center of Neurology»

Adasheva T.V.

Russian University of Medicine

Antonova K.V.

Scientific Center of Neurology»

Maksimova M.Y.

Research Center of Neurology

Received:

19.07.2024

Accepted:

23.08.2024

Close metadata

References:

  1. Maksimova MY, Chugunova SA. Key Risk Factors for Intracerebral Hemorrhage According to Regional Population-Based Stroke Registry. Annals of Clinical and Experimental Neurology. 2024;18(1):5-11. (In Russ.). https://doi.org/10.54101/ACEN.2024.1.1
  2. Tanashyan MM, Orlov SV, Medvedev RB, et al. Metabolic syndrome and cerebrovascular disorders. Annals of Clinical and Experimental Neurology. 2009;3(3):41-47. (In Russ.).
  3. Maksimova MY, Airapetova AS. Does gender influence the clinical characteristics of ischaemic stroke in patients aged 45–74 years? Annals of Clinical and Experimental Neurology. 2021;15(1):32-42. (In Russ.). https://doi.org/10.25692/ACEN.2021.1.4
  4. Maksimova MY, Sazonova VY, Ayrapetova AS. Gender features in cerebrovascular disorders in different age groups. Annals of Clinical and Experimental Neurology. 2019;13(3):11-19. (In Russ.). https://doi.org/10.25692/ACEN.2019.3.2
  5. Maksimova MYu. Age and gender differences of ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(5-2):141. (In Russ.). https://doi.org/10.17116/jnevro201911905S
  6. Maximova MYu, Sazonova VYu. Factors that pre-determine the main subtypes of ischemic stroke in middle-aged and senior women. Annals of Clinical and Experimental Neurology. 2023;17(1):5-13. (In Russ.). https://doi.org/10.54101/ACEN.2023.1.1
  7. Maksimova MYu, Sazonova VYu. Risk factors associated with the development of the main subtypes of ischemic stroke in men aged 45 to 74 years. S.S. Korsakov Journal of Neurology and Psychiatry. 2022;122(12-2):5-11. (In Russ.). https://doi.org/10.17116/jnevro20221221225
  8. Maksimova MYu, Airapetova AS. Gender differences in stroke risk factors. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(12-2):58-64. (In Russ.). https://doi.org/10.17116/jnevro201911912258
  9. Adasheva TV, Samorukova EI, Gubernatorova EE, et al. Anticoagulant therapy for non-valvular atrial fibrillation patients with CHA2DS2-VASC score 1 (regardless of gender): A personalized approach based on risk/benefit analysis. Therapy. 2023;9(4):66-76. (In Russ.). https://doi.org/10.18565/therapy.2023.4.66-76
  10. Maksimova MYu. Current opportunities for secondary prevention of atherothrombotic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(8):97-105. (In Russ.). https://doi.org/10.17116/jnevro202112108197
  11. Tanashyan MM, Kuznetsova PI, Raskurazhev AA. Expanding the possibilities of antithrombotic therapy of cerebrovascular pathology. S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(4):123-128. (In Russ.). https://doi.org/10.17116/jnevro2020120041123
  12. Shishkova VN, Adasheva TV. Cerebrovascular disease in patients with type 2 diabetes mellitus. S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(6):114-118. (In Russ.). https://doi.org/10.17116/jnevro2021121061114
  13. Tanashyan MM, Antonova KV, Lagoda OV, et al. Acute stroke and type 2 diabetes. Annals of Clinical and Experimental Neurology. 2014;8(3):4-8. (In Russ.).
  14. Shchulkin AV. A modern concept of antihypoxic and antioxidant effects of mexidol. S.S. Korsakov Journal of Neurology and Psychiatry. 2018;118(12-2):87-93. (In Russ.). https://doi.org/10.17116/jnevro201811812287
  15. Shchulkin AV, Kazakhmedov ER, Galochkin SA, et al. Effects of mexidol in patients with chronic brain ischemia and chronic heart failure (II-III functional class). Russian Journal of Cardiology and Cardiovascular Surgery. 2020;13(5):427-434. (In Russ.). https://doi.org/10.17116/kardio202013051427
  16. Fedin AI, Zaharov VV, Tanashyan MM, et al. Results of an international multicenter, randomized, double-blind, placebo-controlled study assessing the efficacy and safety of sequential therapy with Mexidol and Mexidol FORTE 250 in patients with chronic brain ischemia (MEMO). S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(11):7-16. (In Russ.). https://doi.org/10.17116/jnevro20211211117
  17. Martynov AI, Tanashyan MM, Malyavin AG, et al. Resolution of the Expert Council «Possibilities of neuroprotective therapy in patients with arterial hypertension and cognitive disorders». Therapy. 2023;9(10):148-158. (In Russ.). https://doi.org/10.18565/therapy.2023.10.148-158
  18. Tanashyan MM, Lagoda OV, Antonova KV. Chronic cerebrovascular diseases associated with metabolic syndrome: new treatment approaches. S.S. Korsakov Journal of Neurology and Psychiatry. 2012;112(11):21-26. (In Russ.).
  19. Stakhovskaya LV, Mkhitaryan EA, Tkacheva ON, et al. Efficacy and safety of mexidol across age groups in the acute and early recovery stages of hemispheric ischemic stroke (results of additional sub-analysis of a randomized double blind multicenter placebo-controlled study, in parallel groups trial EPICA). S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(8-2):49-57. (In Russ.). https://doi.org/10.17116/jnevro202012008249
  20. Shchepankevich LA, Nikolaev YuA, Dolgova NA, Chipova DT. Optimization of hypolipidemic therapy in patients with ischemic stroke and diabetes mellitus. S.S. Korsakov Journal of Neurology and Psychiatry. 2016;116(2):42-45. (In Russ.). https://doi.org/10.17116/jnevro20161162142-45
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.